Boosting the levels of Akkermansia muciniphila in mouse guts slowed the progression of an ALS-like disease, while two other microbiome members were associated with more severe symptoms.
A study suggests that the direct transfer of DNA methylation marks from one generation to the next is much less common than scientists previously thought.